Biora Therapeutics

unknown
unknown
Stage
2
Investors

About

Biora Therapeutics develops needle-free, oral delivery technologies for large molecule therapeutics, aiming to replace injections and improve chronic disease management through platforms like BioJet and NaviCap.

Explore Biora Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.